当前位置:首页 - 行情中心 - 冠昊生物(300238) - 财务分析 - 现金流量表

冠昊生物

(300238)

  

流通市值:42.50亿  总市值:42.50亿
流通股本:2.65亿   总股本:2.65亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金213,008,492.08101,644,327.74405,600,477.34299,990,469.88
  收到的税费返还--1,075,5171,075,517
  收到其他与经营活动有关的现金7,810,201.456,246,407.523,947,764.0422,004,759.29
  经营活动现金流入小计220,818,693.53107,890,735.24430,623,758.38323,070,746.17
  购买商品、接受劳务支付的现金32,258,121.1117,166,330.3977,269,175.9863,096,441.91
  支付给职工以及为职工支付的现金54,933,456.8333,739,974.43105,614,558.2682,055,178.07
  支付的各项税费23,927,704.187,383,196.7939,843,932.3526,690,674.57
  支付其他与经营活动有关的现金70,420,283.1634,530,475.83158,341,294.8118,886,417.91
  经营活动现金流出小计181,539,565.2892,819,977.44381,068,961.39290,728,712.46
  经营活动产生的现金流量净额39,279,128.2515,070,757.849,554,796.9932,342,033.71
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额27,914.3524,119.3598,55016,000
  收到的其他与投资活动有关的现金---262,066.88
  投资活动现金流入小计27,914.3524,119.3598,550278,066.88
  购建固定资产、无形资产和其他长期资产支付的现金24,535,775.0824,035,408.2576,203,040.1953,933,403.09
  投资支付的现金--5,281,026.873,000,000
  取得子公司及其他营业单位支付的现金898,382.18-3,563,536.93,200,000
  支付其他与投资活动有关的现金-898,382.18--
  投资活动现金流出小计25,434,157.2624,933,790.4385,047,603.9660,133,403.09
  投资活动产生的现金流量净额-25,406,242.91-24,909,671.08-84,949,053.96-59,855,336.21
三、筹资活动产生的现金流量:
  吸收投资收到的现金6,101,3006,101,300--
  其中:子公司吸收少数股东投资收到的现金-6,101,300--
  取得借款收到的现金24,000,00024,000,00085,000,00072,000,000
  筹资活动现金流入小计30,101,30030,101,30085,000,00072,000,000
  偿还债务支付的现金2,000,0001,000,00030,800,00029,800,000
  分配股利、利润或偿付利息支付的现金1,941,819.45998,643.072,464,230.591,691,427.81
  支付其他与筹资活动有关的现金3,451,605.57867,268.628,141,238.844,723,528.35
  筹资活动现金流出小计7,393,425.022,865,911.6941,405,469.4336,214,956.16
  筹资活动产生的现金流量净额22,707,874.9827,235,388.3143,594,530.5735,785,043.84
四、汇率变动对现金及现金等价物的影响-113,482.72-25,515.77175,121.04-30,661.74
五、现金及现金等价物净增加额36,467,277.617,370,959.268,375,394.648,241,079.6
  加:期初现金及现金等价物余额104,483,800.11104,483,800.1196,108,405.4796,108,405.47
  期末现金及现金等价物余额140,951,077.71121,854,759.37104,483,800.11104,349,485.07
补充资料:
  净利润16,512,890.17-16,607,493.45-
  资产减值准备1,736,227.74-24,515,652.84-
  固定资产和投资性房地产折旧6,267,314.08-10,822,046.1-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧6,267,314.08-10,822,046.1-
  无形资产摊销4,013,956.34-9,768,134.67-
  长期待摊费用摊销503,609.34-1,010,423.93-
  处置固定资产、无形资产和其他长期资产的损失5,569.63--32,334.57-
  固定资产报废损失12,808.87-55,102.05-
  财务费用2,167,804.25-1,718,844.26-
  投资损失-143,125--606,241.58-
  递延所得税-352,617.19--1,578,677.87-
  其中:递延所得税资产减少221,555.25--3,454,659.62-
    递延所得税负债增加-574,172.44-1,875,981.75-
  存货的减少4,468,165.58--2,127,962.49-
  经营性应收项目的减少411,121.83-19,959,200.26-
  经营性应付项目的增加1,254,118.81--36,825,880.67-
  现金的期末余额140,951,077.71-104,483,800.11-
  减:现金的期初余额104,483,800.11-96,108,405.47-
  现金及现金等价物的净增加额36,467,277.6-8,375,394.64-
公告日期2025-08-282025-04-232025-04-232024-10-29
审计意见(境内)标准无保留意见
TOP↑